Covishield vaccine can cause Heart Attack
Statement from AstraZeneca: A recent statement from AstraZeneca acknowledged the potential risk of thrombosis with thrombocytopenia syndrome (TTS) associated with its COVID-19 vaccine, Covishield. Unlike mRNA vaccines, Covishield employs a viral vector platform, using a modified chimpanzee adenovirus to deliver the COVID-19 spike protein. TTS, highlighted by the World Health Organization, emerged as an adverse…